Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Zhongze In-licenses CNS Candidate for Schizophrenia and Parkinson's

publication date: Mar 2, 2022

Shanghai Zhongze Therapeutics in-licensed a CNS candidate from Digestome Therapeutics, a San Francisco biotech. DGX-001 is a oral first-in-class candidate designed to stimulate the central nervous system via the gut-brain-axis using the vagus nerve. The candidate is aimed at treating negative symptoms and cognitive impairment in schizophrenia, and for non-motor symptoms in Parkinson's Disease. Digestome is set to start US clinical trials of DGX-001. Zhongze has two clinical stage CNS candidates and three molecules in pre-clinical development. Terms of the agreement were not disclosed. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here